Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

IMPORTANCE: The optimal maintenance strategy after induction chemotherapy with anti–epidermal growth factor receptor antibody for patients with RAS wild-type metastatic colorectal cancer (mCRC) remains to be debated. OBJECTIVE: To evaluate the efficacy and safety of maintenance therapy with single-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Boige, Valérie, Blons, Hélène, François, Eric, Ben Abdelghani, Meher, Phelip, Jean-Marc, Le Brun-Ly, Valerie, Mineur, Laurent, Galais, Marie Pierre, Villing, Anne-Laure, Hautefeuille, Vincent, Miglianico, Laurent, De La Fouchardière, Christelle, Genet, Dominique, Levasseur, Nadia, Levaché, Charles-Briac, Penel, Nicolas, Mitry, Emmanuel, Jacquot, Stéphane, Aparicio, Thomas, Brument, Emilie, Gourgou, Sophie, Castan, Florence, Bouché, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507485/
https://www.ncbi.nlm.nih.gov/pubmed/37721754
http://dx.doi.org/10.1001/jamanetworkopen.2023.33533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507485/
https://www.ncbi.nlm.nih.gov/pubmed/37721754
http://dx.doi.org/10.1001/jamanetworkopen.2023.33533

Ejemplares similares